Related references
Note: Only part of the references are listed.Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer
Qiaoling Chen et al.
EUROPEAN RADIOLOGY (2023)
Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer
Yifan Zhong et al.
RADIOLOGY (2022)
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk
Bing-Xi He et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2022)
Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?
Runsheng Chang et al.
FRONTIERS IN ONCOLOGY (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Non-Small Cell Lung Cancer, Version 2.2021 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Artificial intelligence-assisted decision making for prognosis and drug efficacy prediction in lung cancer patients: a narrative review
Jingwei Li et al.
JOURNAL OF THORACIC DISEASE (2021)
Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach
Jian-Xian Lin et al.
JAMA NETWORK OPEN (2021)
Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States
Zihan Xu et al.
JAMA NETWORK OPEN (2021)
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images
Panwen Tian et al.
THERANOSTICS (2021)
Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer
Robert Pirker
CURRENT OPINION IN ONCOLOGY (2020)
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis
Urania Dafni et al.
LUNG CANCER (2019)
Radiomics: Data Are Also Images
Mathieu Hatt et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients
Lifeng Yang et al.
EUROPEAN RADIOLOGY (2019)
Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma
Mohammadhadi Khorrami et al.
RADIOLOGY-ARTIFICIAL INTELLIGENCE (2019)
Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy
Anastasia Oikonomou et al.
SCIENTIFIC REPORTS (2018)
Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer
Jianqing Deng et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery
Michelle C. Salazar et al.
JAMA ONCOLOGY (2017)
Computational Radiomics System to Decode the Radiographic Phenotype
Joost J. M. van Griethuysen et al.
CANCER RESEARCH (2017)
Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models
Philipp Kickingereder et al.
RADIOLOGY (2016)
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
James P. B. O'Connor et al.
CLINICAL CANCER RESEARCH (2015)
Impact of Extratumoral Lymphatic Permeation on Postoperative Survival of Non- Small-Cell Lung Cancer Patients
Yuki Matsumura et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Tumour heterogeneity and the evolution of polyclonal drug resistance
Rebecca A. Burrell et al.
MOLECULAR ONCOLOGY (2014)
Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non-Small Cell Lung Cancer
Thida Win et al.
CLINICAL CANCER RESEARCH (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage
Stephane Collaud et al.
LUNG CANCER (2012)
3D Slicer as an image computing platform for the Quantitative Imaging Network
Andriy Fedorov et al.
MAGNETIC RESONANCE IMAGING (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Regression shrinkage and selection via the lasso: a retrospective
Robert Tibshirani
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Asian Ethnicity Is a Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer (NSCLC) and Is Independent of Smoking Status
Sai-Hong Ignatius et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition
Jean-Paul Sculier et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
The IASLC lung cancer staging project: Validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Patti A. Groome et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)